Demand Fundamentals
|
Demand Technicals
Company Profile
Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes specialty pharmaceutical, biologics, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for chronic dry eye, glaucoma, retinal diseases, and ocular surface disease- Botox for certain therapeutic and aesthetic indications- skin care products for acne, psoriasis, and eyelash growth, as well as other prescription and over-the-counter skin care products- and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery- obesity intervention products comprising the Lap-Band System and the Orbera Intragastric Balloon System- and facial aesthetics products. The company sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, and ambulatory surgery centers, as well as to medical practitioners, including ophthalmologists, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, pediatricians, urologists, and general practitioners. It has strategic research collaboration agreements with ExonHit Therapeutics S.A.- Spectrum Pharmaceuticals, Inc.- Pieris AG- and ACADIA Pharmaceuticals Inc. The company was founded in 1948 and is headquartered in Irvine, California.
|
